MedPath

A study to check if C-Reactive Protein is needed before stopping antibiotics in newborn babies suspected to have bacterial infection whose blood cultures are negative

Recruiting
Conditions
Other general symptoms and signs,
Registration Number
CTRI/2020/05/025440
Lead Sponsor
CMC hospital Vellore
Brief Summary

Sepsis is a common cause of morbidity and mortality in the neonatal period.  As progression from initial symptoms to complications like shock, bleeding, cardio-respiratory failure can be rapid, many neonates are started on empirical antibiotics when they have a variety of symptoms of suspected sepsis after a sepsis screen.

Stopping antibiotics if blood culture is negative and baby is well is sometimes challenging. Many clinicians do a C Reactive Protein to decide if it is safe to stop antibiotics in this setting. However as C Reactive Protein can be falsely positive, there can be prolongation of antibiotic usage. Studies have shown that longer antibiotic usage can cause complications. Retrospective studies in very-low birth babies have shown higher mortality and Necrotising Enterocolitis in babies who have received more than 5 days antibiotics.

We propose that if sepsis screen is negative and the baby is well after 24 hours, antibiotics can be stopped if blood culture is negative. Neonates with suspected sepsis will be eligible for the trial if they become asymptomatic within 24 hours of starting antibiotics and fulfill inclusion and exclusion criteria. They will be randomized to either having a C Reactive protein done or no further testing. For the group that has no further testing, antibiotics will be stopped if blood culture is negative at 72 hours. For the group that has C Reactive protein done, antibiotics will be stopped when c Reactive protein is negative. Symptoms of sepsis will be monitored at 15 and 28 days after onset of initial symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
220
Inclusion Criteria

1 Symptoms criteria a Apnea b Hyperthermia c Respiratory distress d Poor feeding e Lethargy f Irritability g Hypothermia h Hypotension i Poor perfusion j vomiting k Feed intolerance l Diarrhea m Seizures n Cyanosis 2 Laboratory criteria a Have a total WBC count more than 5000 per cubic millimeter b Have an Absolute Neutrophil Count more than 1500 per cubic millimeter 3 Baby becomes asymptomatic and are clinically well within 24 hours of suspicion of sepsis with following criteria a Normal activity b Stable temperature c Stable hemodynamic status with no need for inotropes d No respiratory support needed like supplementary oxygen CPAP ventilation.

Exclusion Criteria

1 They have received antibiotics in the past 15 days 2 They have had surgery in the past 7 days 3 Total WBC count less than 5000 per cubic millimeter 4 Have an Absolute Neutrophil Count less than 1500 per cubic millimeter 5 Abnormal activity beyond 24 hours of suspicion of sepsis 6 Unstable temperature beyond 24 hours of suspicion of sepsis 7 Unstable hemodynamic status requiring inotropes 8 Respiratory support needed like supplementary oxygen CPAP ventilation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All babies will be clinically reviewed 15 days after stopping antibiotics to look for any evidence of suspected sepsis15 days after stopping antibiotics
Rates of restarting antibiotics for suspected sepsis within 15 days of stopping antibiotics in the two groups will be compared15 days after stopping antibiotics
If babies have been discharged then this will be done over the phone with parents15 days after stopping antibiotics
This will be also done in Out Patient Department for babies discharged or in the ward if still admitted15 days after stopping antibiotics
Secondary Outcome Measures
NameTimeMethod
Duration of antibiotic therapyIncidence of necrotizing enterocolitis within 28 days of stopping antibiotics

Trial Locations

Locations (1)

Christian Medical College Vellore

🇮🇳

Vellore, TAMIL NADU, India

Christian Medical College Vellore
🇮🇳Vellore, TAMIL NADU, India
Dr Abhijit Nanda
Principal investigator
07508354748
anabhijit7@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.